Dechra Pharmaceuticals PLC — Investor Relations & Filings
Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Consolidated accounts of parent company for subsidiary company period ending 30/06/25 | 2026-03-09 | English | |
| [accounts-with-accounts-type-audit-exemption-subsiduary] made_up_date=2025-06-30 | 2026-03-09 | English | |
| Full accounts made up to 2024-06-30 | 2025-03-03 | English | |
| Holding(s) in Company | 2024-01-23 | English | |
| Holding(s) in Company | 2024-01-18 | English | |
| Holding(s) in Company | 2024-01-18 | English |
Browse filings by year
28 years- 2026 2 filings
- 2025 1 filing
- 2024 45 filings
- 2023 402 filings
- 2022 56 filings
- 2021 57 filings
- 2020 62 filings
- 2019 52 filings
- 2018 72 filings
- 2017 43 filings
- 2016 52 filings
- 2015 46 filings
- 2014 42 filings
- 2013 53 filings
- 2012 8 filings
- 2011 5 filings
- 2010 5 filings
- 2009 1 filing
- 2008 1 filing
- 2007 1 filing
- 2006 1 filing
- 2005 1 filing
- 2004 2 filings
- 2002 1 filing
- 2001 2 filings
- 2000 3 filings
- 1999 1 filing
- 1998 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 46811253 | Consolidated accounts of parent company for subsidiary company period ending 30/06/25 | 2026-03-09 | English | ||
| 46811252 | [accounts-with-accounts-type-audit-exemption-subsiduary] made_up_date=2025-06-30 | 2026-03-09 | English | ||
|
2025
1 filing
| |||||
| 46811255 | Full accounts made up to 2024-06-30 | 2025-03-03 | English | ||
|
2024
12 filings
| |||||
| 1981653 | Holding(s) in Company | 2024-01-23 | English | ||
| 1979380 | Holding(s) in Company | 2024-01-18 | English | ||
| 1980285 | Holding(s) in Company | 2024-01-18 | English | ||
| 1978875 | Holding(s) in Company | 2024-01-17 | English | ||
| 1978948 | Holding(s) in Company | 2024-01-17 | English | ||
| 1978949 | Holding(s) in Company | 2024-01-17 | English | ||
| 1979043 | Holding(s) in Company | 2024-01-17 | English | ||
| 1979139 | Cancellation of listing and admission to trading | 2024-01-17 | English | ||
| 1979150 | Holding(s) in Company | 2024-01-17 | English | ||
| 1978292 | Holding(s) in Company | 2024-01-16 | English | ||
| 1978328 | Form 8.3 - Dechra Pharmaceuticals plc | 2024-01-16 | English | ||
| 1978345 | Holding(s) in Company | 2024-01-16 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Dechra Pharmaceuticals PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4797/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4797 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4797 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4797 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4797}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Dechra Pharmaceuticals PLC (id: 4797)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.